PSYC (PSYC) Long-Term Debt: $0.00 Mil (As of Jun. 2017)


What is PSYC Long-Term Debt?

PSYC PSYC Long-Term Debt is $0.00 Mil as of Jun. 2017.

PSYC's Long-Term Debt for the quarter that ended in Jun. 2017 was $0.00 Mil.

PSYC's annual Long-Term Debt declined from Dec. 2013 ($0.09 Mil) to Dec. 2014 ($0.00 Mil) but then stayed the same from Dec. 2014 ($0.00 Mil) to Dec. 2016 ($0.00 Mil).

PSYC  (OTCPK:PSYC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

PSYC Long-Term Debt Related Terms

PSYC Long-Term Debt Historical Data

* Premium members only.

The historical data trend for PSYC's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PSYC Long-Term Debt Chart

PSYC Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec16
Long-Term Debt
0.22 0.21 0.09 0.00 0.00

PSYC Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Dec14 Mar15 Jun15 Sep15 Mar16 Jun16 Sep16 Dec16 Jun17
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
PSYC (PSYC) has a Long-Term Debt of $0.00 Mil as of Jun. 2017.
Is PSYC's Long-Term Debt too high?
PSYC's current Long-Term Debt is $0.00 Mil.
How does PSYC's Long-Term Debt compare to ARLO and TAQR?
PSYC's Long-Term Debt of $0.00 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Media - Diversified company?
A good Long-Term Debt depends on the Media - Diversified industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. PSYC's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PSYC stock overvalued right now?
PSYC (PSYC) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For PSYC (PSYC), the current Long-Term Debt is $0.00 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PSYC Business Description

Address 2881 South Valley View Boulevard, Suite 9, Las Vegas, NV, USA, 89102
PSYC Corp is a media-focused company serving the expanding industry and community of medicinal psychedelics. Through its media platform, Psychedelic Spotlight, the company has positioned itself right at the very core. These platforms provide the Company with an opportunity to dominate the intersection of cannabis and psychedelics as a media leader. Along with its subsidiary, the group offers public relations and media-focused services to companies within the medicinal psychedelics industry and other niche industries that include cannabis, holistic health, mining and precious metals, and others.